“Everything about the market recovery is not froth”
Axis Mutual Fund's Jinesh Gopani on why he is betting on IT and consumption stocks
N Mahalakshmi - March 01, 2021
The bitter truth
In Bottle of Lies: Ranbaxy and The Dark Side of Indian Pharma, author Katherine Eban investigates the fall of Ranbaxy — a doom of its own making
September 27, 2019
Ceramic Warrior
This little-known firm, which started by making egg trays, has bagged the biggest bulletproof jacket order from the ministry of defence. What made it successful?
Himanshu Kakkar - August 29, 2019
Is it an opportune time to invest in pharma stocks?
Over the past three years, the NSE Pharma Index has fallen 30% even as the benchmark Nifty rose 18%
June 20, 2018
Ray of Hope
The worst seems to be behind for Sun Pharma as its Halol plant seems set for clearance and its specialty portfolio tests water in the US
Khushboo Balani - April 30, 2018
Virtual Identifier
Creating and securing your digital DNA is now a few clicks away with Bitgram
Bhakti Tambe - March 26, 2018
Just what the doctor ordered
The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon
December 23, 2017
Quiet Flier
The shy and reserved Lara Balsara Vajifdar had big shoes to fill, but with her indefatigable approach she has taken Madison World to greater heights
Krishna Gopalan - November 16, 2017
Nursing Back to Health
A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players
Jash Kriplani - October 18, 2017
Is the worst over for pharma stocks?
The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues
July 17, 2017